KVUE insider grant: 189,274 RSUs to CTO with 3-year vesting

Rhea-AI Filing Summary

Kenvue (KVUE) reported an insider transaction on Form 4. The company’s Chief Technology & Data Officer was granted 189,274 restricted stock units on 10/01/2025. Each unit corresponds 1-for-1 to Kenvue common stock and carries an exercise price of $0.

The award vests in three equal installments on 10/01/2026, 10/01/2027, and 10/01/2028, contingent on continued service through each vesting date. Following the grant, 189,274 derivative securities were beneficially owned, reported as Direct (D).

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wondrasch Michael

Role Chief Tech & Data Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	189,274	$0.00	--

Holdings After Transaction: Restricted Stock Units — 189,274 shares (Direct)

Footnotes (1)

1. These units correspond 1 for 1 with the Company's common stock. This award vests in three equal installments on 10/01/2026, 10/01/2027, and 10/01/2028, subject to the reporting person's continued service through such vesting date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wondrasch Michael

(Last) (First) (Middle)

1 KENVUE WAY

(Street)

SUMMIT NJ 07901

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kenvue Inc. [ KVUE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Tech & Data Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	10/01/2025		A		189,274		(2)	(2)	Common Stock	189,274	$0	189,274	D

Explanation of Responses:

1. These units correspond 1 for 1 with the Company's common stock.

2. This award vests in three equal installments on 10/01/2026, 10/01/2027, and 10/01/2028, subject to the reporting person's continued service through such vesting date.

Remarks:

	/s/ Alla Berenshteyn, as attorney-in-fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kenvue (KVUE) disclose in this Form 4?

A grant of 189,274 restricted stock units (RSUs) to the Chief Technology & Data Officer on 10/01/2025.

How do the KVUE RSUs convert into shares?

Each RSU corresponds 1-for-1 with Kenvue common stock.

What is the vesting schedule for the KVUE RSU grant?

The award vests in three equal installments on 10/01/2026, 10/01/2027, and 10/01/2028.

What price is associated with the KVUE RSUs?

The RSUs have an exercise price of $0.

How many derivative securities were owned after the transaction?

189,274 derivative securities beneficially owned, reported as Direct (D).

Who is the reporting person’s role at KVUE?

They are an Officer, serving as Chief Tech & Data Officer.